SEARCH RESULTS FOR: "Tag: MCRB"
REFINE YOUR SEARCH:
RECENT
Last Month(1)
ARTICLES/BLOGS
2019(1)
2017(1)
2016(4)
CATEGORIES
Analyst Update(1)
Buzz Stocks(1)
Intraday Option Activity(2)
Midday Market Check(1)
Stock Market News(1)
Stocks On the Move(2)

3/11/2019 2:24 PM
The shares of Seres Therapeutics Inc (NASDAQ:MCRB) are up 22.5% to trade at $6.26, after the microbiome specialist announced a three-year research collaboration with AstraZeneca (AZN) to study how mi...
3/16/2017 2:34 PM
After an upbeat start, the Dow has since changed directions to follow crude oil into the red. Among specific equities in focus are drug stocks Patheon NV (NYSE:PTHN) and Seres Therapeutics Inc (NASDA...
8/12/2016 11:55 AM
Seres Therapeutics Inc (NASDAQ:MCRB) is blowing up around midday, after FBR Capital offered the embattled biotech stock a vote of confidence. While the brokerage firm did cut its price target to $23 ...
8/1/2016 2:52 PM
Analysts are weighing in on biotech stocks ADMA Biologics Inc (NASDAQ:ADMA), Seres Therapeutics Inc (NASDAQ:MCRB), and Heron Therapeutics Inc (NASDAQ:HRTX). Here's a quick roundup of today's brokerag...
7/29/2016 12:13 PM
The Dow Jones Industrial Average (DJIA) has fought its way back from a sharp morning tumble, as stocks react to mixed earnings reports, bouncing oil prices, and disappointing second-quarter gross d...

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center